Taizhou Zecen Biotech Co.,Ltd.
                                                                                                           
Verified Supplier
15 Years
Since 2011
Menu
Chemicals Chemical Reagents

chemiluminescence immunoassay C-Peptide (CP) for Automatic immunoassay analyzer in DIABETES

Price Negotiable
Price: Negotiable
MOQ: 1
Delivery Time: 15 workdays
Brand: Zecen
Product Description

CLIA Reagents of DIABETES (CP)

 

【expected usage】


For in vitro quantitative detection of C-peptide (C-P) in human serum.


C-Peptide (C-P) is a connecting peptide connecting insulin A chain and B chain in the proinsulin molecule. It consists of 31 amino acid residues to form a connecting peptide with a molecular weight of 3021. Proinsulin is cleaved in the pancreas by proteases and carboxypeptidases to generate one molecule of insulin and one molecule of C-peptide.


C-peptide has no biological activity, is stored in secretory granules together with insulin, and is released from islet B cells to the blood in equimolar proportions together with insulin under glucose stimulation. Substances that stimulate or inhibit insulin secretion also stimulate C-peptide secretion. Under physiological conditions, C-peptide is mainly excreted by the kidneys.


Insulin in circulating blood is partially inactivated in the liver, so the measured plasma insulin cannot accurately reflect the secretion state of pancreatic islet B cells. Since C-peptide is produced in the process of insulin synthesis, its quantity has a parallel relationship with the secretion of insulin, and C-peptide antibodies do not cross-react with insulin, are not affected by exogenous insulin, and are hardly absorbed and absorbed by the liver. Metabolism, the half-life is more than 2 times longer than that of insulin, so the detection of serum C-peptide level can accurately reflect the secretory function of pancreatic islet B cells, and it is not affected by the production of insulin antibodies in the body after long-term insulin injection.


Since the 1970s, C-peptide has been used clinically to assess residual endogenous insulin secretion in diabetic patients. In addition, the determination of serum C-peptide content can also identify various causes of hypoglycemia and identify the type of diabetes.


At present, the commonly used clinical methods for C-peptide detection include enzyme-linked immunosorbent assay, fluorescence immunoassay, immunoturbidimetric assay, and chemiluminescence assay.

 

Test item CP
Specification 100 Test/Box for CIA series
24 Test/Box for POCT
Principle
  •  sandwich method

Component Magnetic Beads
Calibrator Low
Calibrator High
CP Anti
Control 1
Control 2
Accessories Required But Not Provided Substrate
Washing solution
Sample material serum
Sample volume More than 200μL
Storage 2-8℃

 

 

All test we can provide:

 

Thyroid TSH
TT3
TT4
FT3
FT4
TGAb
TPOAb
TRAb
TG
Fertility FSH
PRL
LH
E2
TESTO
PROG
HCG
P/H-hcg
AMH
Glycometabolism & Hypophyseal Hormone C-P
INS
Hepatic Fibrosis PIIINP
HA
LN
CIV
Tumor Markers CEA
AFP
CA125
CA19-9
CA15-3
CA50
CA72-4
CA242
T-PSA
F-PSA
TK1
FERRITIN
SCC
NSE
CYFRA21-1
HE4
S100
Hp-Ab
TPS
TNF-α
GP73
PIVKAⅡ
PACP
Inflammation Monitoring IL-6
PCT
CRP
CAA
Cardiac cTn
MYO
CK-MB
HFABP
NT-pro-BNP
D-Dimer
HCY
BNP
Lp-pla2
ST2
TORCH  
Infectious HBsAg
HBsAb
HBeAg
HBeAb
HBcAb
Anti-HCV
Anti-HIV
Anti-TP
NP-IgG
NP-IgM
Kidney Function NGAL
H-ALB
RBP
Cys-C
β2-MG
Gastric Mucosa Function PGⅠ/Ⅱ
PRO-GRP
GRP-17

 

 

 

 

 

 

 

 

Get in Touch

Have questions about our products or want to discuss a custom order? Our team is ready to help you.

Company Taizhou Zecen Biotech Co.,Ltd.
Location Building G62, Phase 4 Plant, China Medical City, Taizhou City, Jiangsu Province
Contact Person Liu

Request A Quote

Please check your email address.
Your message must be at least 20 characters.